Gryphon Bio, Inc.

About:

Diagnostic-Powered Therapeutics for Brain Health

Website: https://www.gryphonbio.com/

Description:

Gryphon Bio is a clinical stage company created to harness our co-founders' discovery, over more than 20 years of -omic research, of unexpected waves of 1000s of brain molecules in the blood. The levels of brain-specific molecules in the blood change over time, like waves in the ocean, and can serve as biomarkers for novel blood tests of brain health. ​Mission: To develop and market novel blood tests for brain health. Vision: To pioneer novel blood tests to improve the lives of patients.

Total Funding Amount:

$13.6M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2018-04-18

Contact Email:

bd(AT)gryphonbio.com

Founders:

Kevin Wang, PhD, Will Haskins, PhD

Number of Employees:

1-10

Last Funding Date:

2023-10-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai